torcetrapib

美 　英

• 網(wǎng)絡托徹普；托斯瑞比；托塞匹布

例句

Pfizer suddenly shut down the trial of torcetrapib and announced that the drug would not make it to market.

輝瑞突然中止了torcetrapib的試驗，并宣布該藥品將不可能面市銷售。

But torcetrapib's failure could be the bitter medicine that Pfizer's entrenched bureaucracy needs to make it accept change.

但要治療輝瑞根深蒂固的官僚作風，使其不得不接受變革，torcetrapib的失敗可能是一劑苦口良藥。

Torcetrapib's failure, Dr. Taylor said, shows that lowering cholesterol alone does not prove a drug will benefit patients.

對于Torcetrapib臨床試驗的失敗，Taylor博士說，單純地降低血液中膽固醇含量并不能代表一種藥物對患者有益。

The drug, called torcetrapib, also reduced LDL, the bad cholesterol.

這種被命名為torcetrapib的藥物還可降低有害膽固醇LDL的含量。

The latest study was small, involving just 19 patients, but its striking results suggest torcetrapib can have a powerful effect.

最近進行的研究規(guī)模較小，僅有19名患者參加，但是其結果具有顯著意義，提示torcetrapib具有很強的效應。